Lawrence Chen, DPM
Podiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 4 carriers
- Office
- 1
Offices
1 location · Bruce I Lerman Dpm Inc · 5 clinicians in this group
Hospitals listed: 057002 · 059175 · Community Hospital of the Monterey Peninsula · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
11 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (408) 292-8800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$249,084
Medicare paid this office $249,084 for 368 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 242 | $39,802 | $84 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 32 | $14,806 | $128 |
| Removal of fingernails or toenails, 6 or more nails | 194 | $12,507 | $42 |
| Short return visit (20+ min) | 58 | $11,386 | $56 |
| Removal of skin and tissue, 20.0 sq cm or less | 29 | $9,468 | $110 |
See all 16 services
| Short return visit (20+ min) | 242 | $39,802 | $84 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 32 | $14,806 | $128 |
| Removal of fingernails or toenails, 6 or more nails | 194 | $12,507 | $42 |
| Short return visit (20+ min) | 58 | $11,386 | $56 |
| Removal of skin and tissue, 20.0 sq cm or less | 29 | $9,468 | $110 |
| Removal of noncancer thickened skin growth, 2-4 growths | 53 | $5,967 | $80 |
| Removal of skin and tissue, 20.0 sq cm or less | 52 | $5,535 | $44 |
| New patient visit (30+ min) | 45 | $4,399 | $98 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $2,477 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,460 | $112 |
| Return visit (30+ min) | 14 | $2,088 | $116 |
| New patient visit (30+ min) | 26 | $1,743 | $67 |
| X-ray of foot, minimum of 3 views | 24 | $1,718 | $35 |
| Removal of fingernails or toenails, 1-5 nails | 20 | $926 | $31 |
| Return visit (30+ min) | 11 | $914 | $83 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $287 | $19 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 1128 | More than 93% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1100 | More than 99% of doctors who do this |
| Removal or shaving of skin growth | 476 | More than 95% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
368 Original Medicare patients in 2024. Average age 77 · Under 65 7% · 85 and older 21% · Women 51% · Also on Medicaid 20% · Health risk score 2.10. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 38% · Chronic kidney disease 35% · Heart failure 27% · Atrial fibrillation 25% · Depression 19% · COPD 17% · Cancer 15% · Dementia 12% · Stroke 11%.
The office billed $509,039, Medicare allowed $312,904 and paid $249,084; for 2,016 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 368 | 2,016 | 77 | 2.10 | $509,039 | $249,084 |
| 2023 | 14 | 24 | 69 | 6.20 | $29,981 | $2,531 |
| 2022 | 11 | 29 | 65 | 2.39 | $54,898 | $4,958 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$6,908 in 2024
Medicaid paid $6,908 for 1,038 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 294 | $3,064 |
| Service | 108 | $1,962 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 73 | $1,400 |
| Short return visit (20+ min) | 105 | $365 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 35 | $75 |
| Service | 73 | $42 |
| Medication list documented in medical record (COA) | 226 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 64 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 60 | $0 |
| 2024 | 1,038 | 9 | 30 | $6,908 |
| 2023 | 243 | 3 | 19 | $1,665 |
See the largest Medicaid services in earlier years
2023
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 61 | $862 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 104 | $665 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 78 | $138 |
Drugs they prescribed that Part D paid
$14,154
Pharmacies billed $14,154 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
127 generic and 12 brand-name prescriptions · $14,154 in drug cost · 28 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Santyl | 12 | $13,257 | $1,105 |
| Mupirocin | 86 | $584 | $7 |
| Cephalexin | 11 | $37 | $3 |
Year by year
| 2024 | 139 | 88 | None | 9% | $14,154 |
| 2023 | 181 | 91 | None | 12% | $18,600 |
| 2022 | 32 | 21 | None | None | $2,324 |
| 2021 | 29 | 21 | 69% (20) | 0% | $280 |
| 2020 | 74 | 29 | 41% (30) | None | $1,469 |
| 2019 | 25 | 18 | 56% (14) | 0% | $286 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Santyl | 19 | $14,100 | $742 |
| Mupirocin | 106 | $913 | $9 |
| Cephalexin | 26 | $245 | $9 |
2021: 1 drug
| Oxycodone-Acetaminophen | 19 | $143 | $8 |
2020: 2 drugs
| Oxycodone-Acetaminophen | 22 | $207 | $9 |
| Ibuprofen | 13 | $44 | $3 |
Money from drug and device companies
$2,398 in 2025
| 2025 | 10 | 44 | None | $2,398 |
| 2024 | 6 | 49 | $5,775 | $8,295 |
| 2023 | 9 | 65 | $3,375 | $8,614 |
| 2022 | 6 | 42 | None | $5,818 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $1,468 | 14 payments
|
| Smith+Nephew | Stravix | $292 | 12 payments
|
| Boston Scientific | Watchman Flx | $161 | 3 payments
|
| Organogenesis | Puraply Wound Matrix | $140 | 1 payment
|
| MIMEDX Group | None | $138 | 6 payments
|
| Integra LifeSciences | Integra | $58 | 2 payments
|
See all 44 published payments
| Smith+Nephew | Meals · 2025-12-10 | Oasis | $22 |
| Smith+Nephew | Meals · 2025-12-09 | Collagenase Santyl | $23 |
| Evolution Surgical | Meals · 2025-11-23 | None | $22 |
| Smith+Nephew | Meals · 2025-10-29 | Stravix | $120 |
| Smith+Nephew | Meals · 2025-10-21 | Grafix | $34 |
| Integra LifeSciences | Meals · 2025-09-30 | Integra | $26 |
| MIMEDX Group | Meals · 2025-09-11 | None | $29 |
| Smith+Nephew | Meals · 2025-09-09 | Collagenase Santyl | $8 |
| Boston Scientific | Meals · 2025-09-08 | Watchman Flx | $119 |
| Smith+Nephew | Meals · 2025-08-19 | Collagenase Santyl | $17 |
| Boston Scientific | Meals · 2025-08-18 | Watchman Flx | $29 |
| Stryker | Meals · 2025-08-06 | N/A | $18 |
| Stryker | Meals · 2025-07-22 | Prostep Mica | $21 |
| Biotissue Holdings | Meals · 2025-06-25 | None | $109 |
| Smith+Nephew | Meals · 2025-06-25 | Collagenase Santyl | $10 |
| MIMEDX Group | Meals · 2025-06-19 | None | $27 |
| Smith+Nephew | Meals · 2025-06-11 | Collagenase Santyl | $8 |
| Biotissue Holdings | Meals · 2025-06-05 | None | $126 |
| MIMEDX Group | Meals · 2025-05-29 | None | $23 |
| Biotissue Holdings | Meals · 2025-05-29 | None | $155 |
| Vertex Pharmaceuticals | Meals · 2025-05-22 | Journavx | $29 |
| Biotissue Holdings | Meals · 2025-05-21 | None | $145 |
| Biotissue Holdings | Meals · 2025-05-14 | None | $129 |
| Biotissue Holdings | Meals · 2025-05-07 | None | $36 |
| Biotissue Holdings | Meals · 2025-05-06 | None | $106 |
| MIMEDX Group | Meals · 2025-04-24 | None | $33 |
| Biotissue Holdings | Meals · 2025-04-17 | None | $145 |
| Biotissue Holdings | Meals · 2025-04-12 | None | $101 |
| Organogenesis | Meals · 2025-04-09 | Puraply Wound Matrix | $140 |
| Smith+Nephew | Meals · 2025-03-26 | Grafix | $9 |
| Smith+Nephew | Meals · 2025-03-25 | Collagenase Santyl | $8 |
| Amgen | Meals · 2025-03-24 | Krystexxa | $31 |
| MIMEDX Group | Meals · 2025-03-20 | None | $12 |
| Smith+Nephew | Meals · 2025-03-19 | Collagenase Santyl | $8 |
| Integra LifeSciences | Meals · 2025-03-07 | Integra | $32 |
| Boston Scientific | Meals · 2025-03-05 | General - Pain Management | $13 |
| Biotissue Holdings | Meals · 2025-02-28 | None | $168 |
| Biotissue Holdings | Meals · 2025-02-27 | None | $23 |
| Amgen | Meals · 2025-02-26 | Krystexxa | $21 |
| Smith+Nephew | Meals · 2025-02-20 | Stravix | $25 |
| Biotissue Holdings | Meals · 2025-02-04 | None | $106 |
| Biotissue Holdings | Meals · 2025-01-28 | None | $103 |
| MIMEDX Group | Meals · 2025-01-14 | None | $15 |
| Biotissue Holdings | Meals · 2025-01-03 | None | $14 |
See earlier years (2024, 2023, 2022)
2024: $8,295
| Biotissue Holdings | Neox | $7,471 | 31 payments
|
| Stryker | Prostep | $257 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System | $190 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $151 | 11 payments
|
| Boston Scientific | None | $133 | 1 payment
|
| Organogenesis | None | $93 | 4 payments
|
2023: $8,614
| Biotissue Holdings | Neox | $5,644 | 18 payments
|
| Arthrex | None | $1,202 | 10 payments
|
| Evolution Surgical | None | $676 | 5 payments
|
| Organogenesis | Puraply | $331 | 13 payments
|
| Smith+Nephew | Collagenase Santyl | $277 | 13 payments
|
| Stryker | Ortholoc 2 Lapifuse | $180 | 2 payments
|
| Nevro | Senza | $166 | 2 payments
|
| Hydrofera | Hydrofera Blue | $123 | 1 payment
|
| Integra LifeSciences | Integra | $16 | 1 payment
|
2022: $5,818
| Orthofix Medical | Truelok | $1,409 | 13 payments
|
| Evolution Surgical | None | $1,216 | 2 payments
|
| Paragon 28 | Product Portfolio | $1,210 | 5 payments
|
| Rock Medical Orthopedics | None | $1,200 | 1 payment
|
| BioTissue Holdings | Neox | $629 | 6 payments
|
| Smith+Nephew | Grafix Pl | $153 | 8 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265927115
- Licence
- CA E5849
- Trained
- California School of Podiatric Medicine, 2019
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213E00000X (213E00000X); Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 555 Knowles Dr Ste 117, Los Gatos, CA, 95032
- NPI first listed
- 2018-06-23
- NPI last updated
- 2022-06-08
- NPI record certified
- 2022-06-08
This is when the NPI record was last certified, not a medical board exam.